MAVENCLAD
We are very excited to announce we have been selected as part of the limited specialty network for MAVENCLAD (cladribine), a prescription medicine used to treat relapsing forms of multiple sclerosis (MS).
We are very excited to announce we have been selected as part of the limited specialty network for MAVENCLAD (cladribine), a prescription medicine used to treat relapsing forms of multiple sclerosis (MS).
We see strong results negotiating directly with drug manufacturers and implementing the cost-plus model to help reduce costs for patients.